誉衡药业（002437）7月30日主力资金净流入4019.77万元

Core Points - The stock price of Yuheng Pharmaceutical (002437) closed at 3.62 yuan on July 30, 2025, with an increase of 2.55% and a turnover rate of 12.89% [1] - The company reported a total revenue of 551 million yuan for Q1 2025, a year-on-year decrease of 7.06%, while net profit attributable to shareholders was 60.25 million yuan, an increase of 15.24% [1] - The company has a registered capital of 2.27 billion yuan and a paid-in capital of 105 million yuan [1] Financial Performance - Total revenue for Q1 2025: 5.51 billion yuan, down 7.06% year-on-year [1] - Net profit attributable to shareholders: 6025.23 million yuan, up 15.24% year-on-year [1] - Non-recurring net profit: 4973.30 million yuan, up 54.74% year-on-year [1] - Current ratio: 1.061, quick ratio: 0.853, debt-to-asset ratio: 31.97% [1] Investment and Intellectual Property - Yuheng Pharmaceutical has invested in 19 companies and participated in 423 bidding projects [2] - The company holds 701 trademark registrations and 28 patents [2] - Additionally, it possesses 9 administrative licenses [2]